“…Personalized treatment for cognitive disruptions related to mental disorders relies on developing an understanding of individual differences in cognition. Genetic variation may be one component driving individual differences in cognitive ability (Friedman et al, 2008 ; Stelzel et al, 2010 ; Barnett et al, 2011 ; Markett et al, 2011 ; van Holstein et al, 2011 ; Colzato et al, 2013a , b ; Ross et al, 2015 ). One gene that has been linked to symptoms of mental disorders, such as depression (Dannlowski et al, 2009 ) and anxiety (Tadic et al, 2003 ) as well as cognitive abilities, including episodic memory (Mueller et al, 2014 ), is the monoamine oxidase A gene ( MAO-A ).…”